Bizotic H1 FY27: standalone PAT +88% YoY to Rs15.8 Cr, but margin dips, EPS -74% on dilution
PAT +88.31% YoY · revenue +172.17% · margins compressing
₹200.83 Cr
+172.17% YoY
₹15.78 Cr
+88.31% YoY
7.86%
-3.5pp YoY
₹2.73
Bizotic Commercial's standalone H1 FY27 (half year ended 30 September 2026) revenue came in at ₹200.83 Cr, up 172% YoY from ₹73.78 Cr in H1 FY26, with net profit of ₹15.78 Cr, up 88% YoY from ₹8.38 Cr. There were no exceptional items in either period, so this is a clean YoY comparison. Basic EPS fell 74% to ₹2.73 (half-year, not annualised) from ₹10.42, purely a function of a 7.2x increase in the paid-up equity base rather than weaker fundamentals.
Q2 FY-2027 vs prior quarters
Profit growth lagged revenue growth by a wide margin because the cost of stock-in-trade (₹17,424.60 Lacs, ~97% of total expenses) scaled faster than revenue, pulling net profit margin down to 7.86% from 11.35% and PBT margin to 10.57% from 15.18%. Employee costs and finance costs roughly doubled to tripled YoY (₹144.33 Lacs and ₹10.53 Lacs) but remain small next to the cost-of-goods line, so the compression looks like a trading-mix/pricing effect in the core business rather than overhead creep.
The stock went into the print at ₹92.2, down 18.5% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 3 consecutive quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
No exceptional items in either period — results unaudited but reviewed under SRE 2410 with no modified opinion
Single reportable segment (Trading) under Ind-AS 108 — no dividend recommended for FY26
No brokerage previews or consensus estimates for this micro-cap (BSE scrip 543926) turned up in a web search, and the company has no formal guidance on record in our database or the filing, so both vsStreet and vsGuidance are unknown — flagged rather than guessed. Beyond the board-meeting outcome letter, no separate management press release accompanies this filing, so there is no quoted management framing to reconcile against the print. The paid-up equity base jumped from ₹804.00 Lacs to ₹5,785.20 Lacs via a preferential issue (₹5.742 Cr raised, per the funds-utilization statement, directed to working capital) — the direct cause of the EPS decline. The board separately approved a fresh share capital increase/preferential issue price on 30 September 2026, with an EGM held 23 October 2026, just ahead of this results announcement, meaning further dilution is already in motion.
W1
Incremental dilution from the share capital increase/preferential issue approved 30 Sep 2026 (EGM 23 Oct 2026) — watch resulting share count and EPS impact in H2 FY27
W2
NPM trajectory — compressed to 7.86% in H1 FY27 from 11.35% in H1 FY26; watch whether the trading-cost line stabilizes as revenue scales
W3
H2 FY27 pacing — H1 FY27 PAT (₹15.78 Cr) is already 87% of FY26's full-year audited PAT (₹18.09 Cr); watch whether the growth rate sustains or decelerates